Form EFFECT Cidara Therapeutics,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 9, 2026 |
| Accession Number: | 0001193125-26-005766 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tabby Launches Tabby 2.0 With Tabby Talk, an AI Agent Answering Financial Questions and Completing Bookkeeping Tasks
- U.S. Ski & Snowboard Names Dr. Joseph J. Ruzbarsky Head Physician of U.S. Snowboard Team
- Boys & Girls Clubs of America and Panda Cares Foundation Expand Educational Access in Florida With Two New Centers of Hope
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share